In this very important episode, we welcome Dr. Bertha Madras who has been at the forefront of discussions around drug policy for decades. Among the many areas she focuses on, we discussed her research into psychedelic drug therapies and her very concerned viewpoint. With billions of dollars pouring into this emerging field, Dr. Madras sheds light on the complexities and controversies surrounding these treatments and how the crucial cautionary narratives are omitted, potentially misleading the public about the realities of this therapy. She also talks about the dangers of the FDA's recommendation to reschedule marijuana from Schedule I to Schedule III and the potentially hazardous implications of this proposed change. Listening to Bertha discuss drug abuse as a whole makes this episode a must-listen.